Skip to content

Unloader One Study on Knee Osteoarthritis Hässleholm Sweden

The Effect of the Unloader One® Knee Brace on Symptoms in Patients With Knee Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03454776
Enrollment
150
Registered
2018-03-06
Start date
2012-04-30
Completion date
2014-10-31
Last updated
2019-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Brief summary

The purpose of this study is to assess the effect of the Unloader one brace on the clinical symptoms of patients with knee osteoarthritis (OA) by comparing a functioning brace with a dummy.

Detailed description

The purpose of this study is to assess the effect of the Unloader one brace on the clinical symptoms of patients with knee OA by comparing a functioning brace with a dummy. The dummy will be manufactured by Össur and has the same look as the real brace, but lacks the fundamental tightening effect of the straps of the real brace (an insert of elastic bands assures this), thereby nullifying its unloading capabilities. In a recent trial by Dr. Ingvarsson, the brace seemed to lessen the pain from knee OA, but no randomised, controlled studies have been conducted. This is mandatory if the effect of the brace and its use as an accepted treatment for knee OA is to be advocated for general use.

Interventions

DEVICEUnloader One brace

A knee brace used to unload affected compartments in osteoarthritic knees

DEVICEPlacebo brace

A knee brace that feels and looks like Unloader One but without active straps facilitating unloading of the knee

Sponsors

Lund University
CollaboratorOTHER
Region Skane
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Intervention model description

Two groups with same problem of osteoarthritis in knee

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Patients fulfilling all criteria listed below will be considered to eligible for participation in the study: * Patient, men and women, age 30 to 70 with knee OA not scheduled for surgery who understand the given information and are willing to participate in this study. * Signed informed patient consent * BMI \< 35 * Knee pain for more than 3 month * Patients with Knee OA Ahlbäck grade 1 and 2 and/or Kellgren-Lawrence 1 and 2 * Patient with arthroscopic OA but do not have regular grade 1 OA

Exclusion criteria

Patient presenting with any of the following will not be included in the study: * prior major surgery to the same knee * patients with a history of stroke or neurological or psychiatric decease that potentially could affect the perception of pain * obesity (BMI \> 35) * active or suspected infection * patients taking opioids or steroids * patients suffering from rheumatoid arthritis or have a immunological depression * patients with other severe medical problems that could affect the perioperative course * the patient had an intraarticular steroid injection in the actual knee during the last 3 months * Patient participating in a clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Knee injury and Osteoarthritis Outcome Score (KOOS)one yearStandardized questionaire for knee problems, divided into 5 subscores of pain, symptoms, activity of daily living, sports/recreation and quality of life. Each subscore is presented from 0 (worst) to 100 (best).
Knee Society Score (KSS)one yearStandardized outcome measure for knee problems presented in two subgroups of KSS Score and KSS Function, presented on a range from 0 (worst) to 100 (best)
Visual Analogue Scale (VAS)one yearVAS is presented as a range from 0 (no pain) to 100 (worst possible pain)
EQ-5Done yearEQ-5D comprises two distinct self-report elements, providing three principal approaches to analysis(1) the EQ-5D profile: the patients' self reported health on the dimensions/levels of the descriptive system (2) the EQ-VAS: the patients' own global rating of their overall health, on a scale from 0 (worst possible health) to100 (best possible health)• Both types of data can be the focus of analysis, plus(3) Profiles can be summarized using 'value sets' (EQ-5DIndex) which reflect the preferences of the general public.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026